Cargando…
Machine Learning Algorithms Identify Clinical Subtypes and Cancer in Anti-TIF1γ+ Myositis: A Longitudinal Study of 87 Patients
BACKGROUND: Anti-TIF1γ antibodies are a class of myositis-specific antibodies (MSAs) and are closely associated with adult cancer-associated myositis (CAM). The heterogeneity in anti-TIF1γ+ myositis is poorly explored, and whether anti-TIF1γ+ patients will develop cancer or not is unknown at their f...
Autores principales: | Zhao, Lijuan, Xie, Shuoshan, Zhou, Bin, Shen, Chuyu, Li, Liya, Pi, Weiwei, Gong, Zhen, Zhao, Jing, Peng, Qi, Zhou, Junyu, Peng, Jiaqi, Zhou, Yan, Zou, Lingxiao, Song, Liang, Zhu, Honglin, Luo, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883045/ https://www.ncbi.nlm.nih.gov/pubmed/35237262 http://dx.doi.org/10.3389/fimmu.2022.802499 |
Ejemplares similares
-
The Roles of TIF1γ in Cancer
por: Yu, Chengpeng, et al.
Publicado: (2019) -
Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
por: Parkes, Joanna E., et al.
Publicado: (2018) -
1. TIF1-γ associated dermatomyositis
por: Waller, Rosemary, et al.
Publicado: (2019) -
Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020) -
A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing
por: Mulhearn, Ben, et al.
Publicado: (2022)